Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News
Die Kommerzialisierung der räumlichen Intelligenz in Billionen-Märkten beginnt jetzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
48 Leser
Artikel bewerten:
(0)

Cardinal Health Introduces New Protexis' Latex Blue With Neu-Thera Surgical Gloves

DUBLIN, Ohio, Oct. 31, 2011 /PRNewswire/ -- Cardinal Health today announced the launch of its new Protexis' Latex Blue with Neu-Thera® sterile latex powder-free surgical gloves with emollient coating.

(Photo: http://photos.prnewswire.com/prnh/20111031/CL95444)

The newest addition to the Protexis' portfolio of powder-free surgical gloves from Cardinal Health, these gloves are made from natural rubber latex and contain 50 micrograms or less of total water extractable protein per square decimeter. Their distinct blue color supports double-gloving initiatives, because the blue base layer provides contrast against a light-colored top glove, helping alert wearers to potentially dangerous breaches or perforations.

Cardinal Health now offers blue underglove solutions in both powder-free latex and synthetic polyisoprene.Clinicians can select the glove type with the barrier protection, comfort, fit and indication properties they need when double-gloving.

Protexis' Latex Blue with Neu-Thera® surgical gloves also include the company's exclusive Neu-Thera® emollient coating which aids in damp and dry donning.The formulation of the Neu-Thera® emollient coating promotes skin moisturization and supports hand hygiene compliance.

"Cardinal Health is dedicated to providing the innovative products clinicians need for protection from perforations and sharps injuries," said Lisa Ashby, president of Category Management at Cardinal Health. "And our addition of the Protexis' Latex Blue with Neu-Thera® surgical gloves to our new Protexis' powder-free surgical glove portfolio marks another step toward Cardinal Health providing a robust portfolio that our customers rely upon so they can perform confidently."

The recently introduced Protexis' brand is the new brand name of the powder-free portfolio of surgical gloves from Cardinal Health, which includes both new and existing Cardinal Health surgical gloves. The new, advanced solutions - Protexis' Latex Hydrogel and Protexis' Latex Blue with Neu-Thera® - join gloves transitioning from already-existing Duraprene', Esteem® and Protegrity® brands.

The new Protexis' naming system is simple, straightforward and easy-to-understand. Its architecture clearly communicates the material from which the gloves are made as well as their primary features and attributes.

All Protexis' surgical gloves are made using an exclusive hand mold with an independent thumb that allows for an anatomical fit and more natural movement in the fingers, thumb and palm. Forming a reliable barrier from fingertips to forearm, the gloves also have roll-down-resistant cuffs.

To learn more about the new Protexis' Latex Blue with Neu-Thera® surgical gloves or the new Protexis' brand, contact Linda McNeilly, director of marketing and product management for surgical gloves at Cardinal Health, at 1-847-887-2027 or linda.mcneilly@cardinalhealth.com.

About Cardinal Health

Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a $103 billion health care services company that improves the cost-effectiveness of health care. As the business behind health care, Cardinal Health helps pharmacies, hospitals, ambulatory surgery centers and physician offices focus on patient care while reducing costs, enhancing efficiency and improving quality. Cardinal Health is an essential link in the health care supply chain, providing pharmaceuticals and medical products to more than 60,000 locations each day. The company is also a leading manufacturer of medical and surgical products, including gloves, surgical apparel and fluid management products. In addition, the company supports the growing diagnostic industry by supplying medical products to clinical laboratories and operating the nation's largest network of radiopharmacies that dispense products to aid in the early diagnosis and treatment of disease. Ranked #19 on the Fortune 500, Cardinal Health employs more than 30,000 people worldwide. More information about the company may be found at cardinalhealth.com and @CardinalHealth on Twitter.

SOURCE Cardinal Health

© 2011 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.